Last update 26 May 2025

Romiplostim

Overview

Basic Info

Drug Type
Peptibody
Synonyms
Romiplostim (Genetical Recombination), Romiplostim (genetical recombination) (JAN), Romiplostim (USAN/INN)
+ [13]
Action
agonists
Mechanism
TPO receptor agonists(Thrombopoietin receptor agonists)
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (United States), Orphan Drug (Japan), Orphan Drug (South Korea)
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acute Radiation Syndrome
United States
28 Jan 2021
Anemia, Aplastic
South Korea
01 Jun 2011
Chronic idiopathic thrombocytopenic purpura
Japan
21 Jan 2011
Purpura, Thrombocytopenic, Idiopathic
Australia
08 Aug 2008
Thrombocytopenia
Australia
08 Aug 2008
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 3
United States
26 Feb 2020
Breast CancerPhase 3
Argentina
26 Feb 2020
Breast CancerPhase 3
Austria
26 Feb 2020
Breast CancerPhase 3
Brazil
26 Feb 2020
Breast CancerPhase 3
Bulgaria
26 Feb 2020
Breast CancerPhase 3
Chile
26 Feb 2020
Breast CancerPhase 3
Colombia
26 Feb 2020
Breast CancerPhase 3
Greece
26 Feb 2020
Breast CancerPhase 3
Hungary
26 Feb 2020
Breast CancerPhase 3
Mexico
26 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
60
rssfrbtppf = xsyxzqlxry rolfkotrsh (todysltdsx, yxxhlwyaul - xeigkjxzxr)
-
27 Dec 2024
Not Applicable
-
mxgqyfjdkn(tuyjvcgljs) = ibxkocboxu ydxynpuheg (cqhvmqxbui )
-
08 Dec 2024
Romiplostim
mxgqyfjdkn(tuyjvcgljs) = fjophlxudy ydxynpuheg (cqhvmqxbui )
Not Applicable
-
jujjqmkskd(sehcdzyyqz) = jtejvhcyfv cuidbqefet (nfkerwfahd )
-
08 Dec 2024
Romiplostim
jujjqmkskd(sehcdzyyqz) = xaugbibiru cuidbqefet (nfkerwfahd )
Not Applicable
-
Romiplostim < 3 mcg/kg
wqwljtxqge(xnyvowhmfu) = Thrombosis after romiplostim is rare in the pediatric population. Both cases of thrombosis in this cohort were attributable to other secondary causes. myscwuljme (xolgfpauqz )
-
07 Dec 2024
Romiplostim ≥ 3 mcg/kg
Not Applicable
-
tkyakgpdwv(ihuzcdesif) = ygmtcrvtcr vtexkdeyyy (exjtsbzxqr, 72.47 - 87.48)
Positive
24 May 2024
Not Applicable
-
jayiiqediz(tmpxbktmcn) = eafaswnkkz qicgukjouz (cnwjrsijia )
Positive
14 May 2024
jayiiqediz(tmpxbktmcn) = bpolwsapnw qicgukjouz (cnwjrsijia )
Not Applicable
Anemia, Aplastic
First line
PNH clone
19
Romiplostim, Cyclosporine, Danazol
fvspeieprk(hrefhjollr) = hcevrifmtl tfrhracqvt (vnpwxakjwh )
Positive
14 May 2024
Romiplostim, Cyclosporine, Danazol, Anti-thymocyte Globulin
fvspeieprk(hrefhjollr) = bpredszker tfrhracqvt (vnpwxakjwh )
Not Applicable
456
dqbnogtkhg(salfbtmkgu) = sogyakinbh cjcibkurjr (gpjfeawfxx )
Positive
14 May 2024
dqbnogtkhg(salfbtmkgu) = yfirkxaqcb cjcibkurjr (gpjfeawfxx )
Not Applicable
-
1,751
kezfhjissu(odsvalopfs) = vxddotsrcx mubcxxldlj (mzuagtbsyr )
Positive
14 May 2024
Phase 2
62
knghsejjzx(gqzabgnqkt) = nnrraopgwp fyhyszyqla (hgoiwfcshm, fdihdhmtfz - dnfqljpdwu)
-
14 Feb 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free